AMAG Pharmaceuticals to Acquire Cord Blood Registry

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. SPY
10. SBUX

Go back to AMAG Pharmaceuticals to Acquire Cord Blood Registry

AMAG Pharma (AMAG) to Acquire Cord Blood Registry in $700M Deal

June 29, 2015 7:01 AM EDT

AMAG Pharma (NASDAQ: AMAG) announced that it has entered into a definitive agreement to acquire Cord Blood Registry® (CBR®), the world's largest stem cell collection and storage company serving pregnant women and their families, for $700 million. The acquisition of CBR would expand AMAG's suite of maternal health offerings and add a high-margin business with complementary commercial capabilities and attractive future growth opportunities to the AMAG portfolio.

CBR owns a state-of-the-art storage facility that houses more than 600,000 preserved umbilical cord blood and tissue stem cell units, which represents more than half... More